Suven Life Science is planning for the investments in new overseas subsidiary. The meeting of Board of Directors of the company will be held March 09, 2019, to consider the same.
Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.